A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia
Clinical trial NCT00300287 · COMPLETED
Trial details
- NCT number
- NCT00300287
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-20
- Primary completion
- 2007-06-26
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.